Novartis Statements
50
Novartis Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
1 657.1
100
1 023.8
70.1
633.3
29.9
—
0
115.8
6.3
327.5
16.3
305.8
13.6
-3.2
-0.2
323.8
12.8
626.4
26.3
213.9
8.2
412.5
18.1
16.71
24.683
1 693.6
100
974.6
56.8
719
43.2
—
0
115.5
6.8
398.8
22.6
320.2
20.6
-11.7
-0.9
293.5
21.4
602
41.2
162.6
11.1
439.4
30.1
17.8
24.685
1 563
100
932.1
60.5
630.9
39.5
—
0
153.4
8.3
495.1
30
135.8
9.5
-7.6
-0.4
247.3
21.5
375.5
30.6
49.2
-2.2
326.3
32.9
13.202
24.709
2 224.4
100
1 084.8
50.3
1 139.6
49.7
—
0
206.7
11.3
685.2
35
454.4
14.7
-9.9
-0.5
333.8
6.8
778.3
21
71
2.9
707.3
18.1
28.64
24.7
1 972.8
100
931.5
50.2
1 041.3
49.8
—
0
466
21
960.1
45.4
81.2
4.4
-17.9
-0.3
203.5
14.6
-229.6
-31.9
-59.4
-8.1
-170.2
-23.8
-6.89
24.7
2 025.9
100
849.8
43.1
1 176.1
56.9
—
0
552.9
26
1 082.7
52.7
93.4
4.2
-30.4
-1.4
128.4
6.1
191.4
8.9
58.4
2.2
133
6.7
5.39
24.65